Hongui Cha
Samsung Medical Center · 128 works · 2,381 citations · h-index 18
Top works
- Lung adenocarcinoma promotion by air pollutants
- Artificial Intelligence–Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as Complementary Biomarker for Immune Checkpoint Inhibition in Non–Small-Cell Lung Cancer
- RETRACTED ARTICLE: Antibodies against endogenous retroviruses promote lung cancer immunotherapy
- HLA-corrected tumor mutation burden and homologous recombination deficiency for the prediction of response to PD-(L)1 blockade in advanced non-small-cell lung cancer patients
- Correlations between metabolic texture features, genetic heterogeneity, and mutation burden in patients with lung cancer
- Synthetic lethality-mediated precision oncology via the tumor transcriptome
- Comprehensive Clinical and Genetic Characterization of Hyperprogression Based on Volumetry in Advanced Non–Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitor
- Tumor Heterogeneity Predicts Metastatic Potential in Colorectal Cancer
- Systematic dissection of tumor-normal single-cell ecosystems across a thousand tumors of 30 cancer types
- LBA1 Mechanism of action and an actionable inflammatory axis for air pollution induced non-small cell lung cancer: Towards molecular cancer prevention
- Dysregulation of cancer genes by recurrent intergenic fusions
- Genomic scoring to determine clinical benefit of immunotherapy by targeted sequencing
- High-Resolution Profiling of Lung Adenocarcinoma Identifies Expression Subtypes with Specific Biomarkers and Clinically Relevant Vulnerabilities
- CRISPR–Cas9 Screening Identifies KRAS-Induced COX2 as a Driver of Immunotherapy Resistance in Lung Cancer
- Transcriptional upregulation of CXCL13 is correlated with a favorable response to immune checkpoint inhibitors in lung adenocarcinoma
- MHC II immunogenicity shapes the neoepitope landscape in human tumors
- Metabolic radiogenomics in lung cancer: associations between FDG PET image features and oncogenic signaling pathway alterations
- Earlier-Phased Cancer Immunity Cycle Strongly Influences Cancer Immunity in Operable Never-Smoker Lung Adenocarcinoma
- Intracellular Adhesion Molecule‐1 Improves Responsiveness to Immune Checkpoint Inhibitor by Activating CD8+ T Cells
- Clinical advantage of targeted sequencing for unbiased tumor mutational burden estimation in samples with low tumor purity